Open AccessClinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis
Author(s) -
Dong Liu,
Jian-Ming Fang,
Xian-Qi Chen
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i24.8547
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , hepatectomy , blood transfusion , liver function , occlusion , blood flow , surgery , liver cancer , gastroenterology , resection
Most patients with primary hepatocellular carcinoma (HCC) have a history of chronic hepatitis B and usually present with varying degrees of cirrhosis. Owing to the special nature of liver anatomy, the blood vessel wall in the liver parenchyma is thin and prone to bleeding. Heavy bleeding and blood transfusion during hepatectomy are independent risk factors for liver cancer recurrence and death. Various clinical methods have been used to reduce intraoperative bleeding, and the Pringle method is most widely used to prevent blood flow to the liver.